Yasuo Suzuki Selected Research

lactosamine

10/2008	Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.
2/2006	Human trachea primary epithelial cells express both sialyl(alpha2-3)Gal receptor for human parainfluenza virus type 1 and avian influenza viruses, and sialyl(alpha2-6)Gal receptor for human influenza viruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuo Suzuki Research Topics

Disease

52	Ulcerative Colitis 07/2022 - 05/2002
43	Human Influenza (Influenza) 01/2021 - 03/2002
36	Crohn Disease (Crohn's Disease) 01/2022 - 05/2002
34	Infections 01/2022 - 12/2002
24	Rheumatoid Arthritis 05/2022 - 12/2002
20	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2022 - 02/2003
19	Influenza in Birds (Avian Flu) 12/2022 - 03/2005
15	Neoplasms (Cancer) 05/2022 - 06/2003
13	Osteoporosis 12/2015 - 02/2004
11	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 12/2021 - 01/2009
11	Virus Diseases (Viral Diseases) 01/2020 - 10/2003
10	Inflammation (Inflammations) 01/2021 - 05/2002
8	Disease Progression 01/2022 - 08/2007
8	Colitis 01/2018 - 03/2003
5	Dermatomyositis (Dermatopolymyositis) 01/2022 - 08/2012
5	Tuberculosis (Tuberculoses) 08/2021 - 01/2018
5	Hemorrhage 01/2021 - 10/2007
5	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2019 - 08/2012
4	Immunoglobulin G4-Related Disease 05/2015 - 06/2012
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 01/2018
3	Enteritis 08/2021 - 04/2004
3	Pathologic Constriction (Stenosis) 01/2020 - 10/2007
3	Necrosis 09/2019 - 11/2010
3	Ulcer 11/2018 - 11/2002
3	Vasculitis (Vasculitides) 11/2018 - 01/2009
3	Fibrosis (Cirrhosis) 02/2017 - 04/2013
3	Parkinson Disease (Parkinson's Disease) 11/2015 - 02/2015
3	Arthritis (Polyarthritis) 01/2014 - 12/2007
3	Rheumatic Diseases (Rheumatism) 06/2012 - 10/2003
3	Hypertrophy 03/2003 - 09/2002
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2022 - 01/2020
2	Lymphadenopathy 01/2022 - 01/2014
2	Spontaneous Remission 01/2022 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 11/2020
2	Fever (Fevers) 01/2022 - 01/2018
2	Hypersensitivity (Allergy) 01/2022 - 01/2007

Drug/Important Bio-Agent (IBA)

23	Neuraminidase (Sialidase)IBA 01/2020 - 10/2003
21	Infliximab (Remicade)FDA Link 08/2021 - 06/2008
15	Pharmaceutical PreparationsIBA 07/2022 - 03/2002
15	GlucocorticoidsIBA 08/2021 - 02/2004
14	Hemagglutinins (Hemagglutinin)IBA 12/2022 - 10/2004
13	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2002
12	Biological ProductsIBA 09/2022 - 02/2004
12	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022 - 12/2002
11	Adalimumab (Humira)FDA Link 10/2021 - 02/2014
11	SteroidsIBA 01/2021 - 09/2002
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 06/2003
10	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 09/2010
8	Viral HemagglutininsIBA 01/2020 - 03/2007
8	Proteins (Proteins, Gene)FDA Link 05/2018 - 10/2004
7	CytokinesIBA 11/2020 - 02/2004
6	vedolizumabIBA 01/2022 - 01/2019
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 03/2003
6	Interleukin-6 (Interleukin 6)IBA 11/2020 - 02/2004
6	Immunoglobulin G (IgG)IBA 05/2015 - 03/2002
5	Polysaccharides (Glycans)IBA 01/2022 - 06/2008
5	Amino Acids FDA Link 01/2020 - 01/2012
5	Monoclonal AntibodiesIBA 09/2019 - 11/2002
5	CarbohydratesIBA 02/2017 - 03/2006
5	MineralsIBA 10/2015 - 01/2005
4	Budesonide (Pulmicort)FDA LinkGeneric 08/2021 - 04/2013
4	VaccinesIBA 01/2021 - 08/2005
4	SugarsIBA 01/2020 - 03/2004
4	LectinsIBA 01/2020 - 03/2008
4	Diphosphonates (Bisphosphonates)IBA 12/2015 - 10/2003
4	LipidsIBA 09/2009 - 03/2003
4	carbosilaneIBA 08/2009 - 02/2007
4	Dendrimers (Dendrons)IBA 08/2009 - 02/2007
4	OligosaccharidesIBA 08/2006 - 11/2002
4	Therapeutic UsesIBA 01/2005 - 11/2002
3	Biosimilar PharmaceuticalsIBA 05/2022 - 10/2019
3	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 07/2016
3	Indigo Carmine (Indigo Blue)IBA 02/2020 - 01/2018
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 04/2015
3	Azathioprine (Imuran)FDA LinkGeneric 09/2019 - 11/2016
3	2-mercaptopurineIBA 09/2019 - 04/2016
3	EnzymesIBA 09/2018 - 03/2002
3	TeaIBA 05/2018 - 01/2012
3	Heparin (Liquaemin)FDA LinkGeneric 01/2016 - 11/2010
3	AutoantibodiesIBA 01/2016 - 08/2012
3	C-Reactive ProteinIBA 08/2015 - 02/2003
3	Oseltamivir (Tamiflu)FDA Link 09/2013 - 10/2005
3	Sulfoglycosphingolipids (Sulfatides)IBA 10/2012 - 10/2003
3	Virus ReceptorsIBA 01/2011 - 02/2006
2	AntibodiesIBA 01/2022 - 01/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2021 - 04/2016
2	CT-P13IBA 08/2021 - 10/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2002
2	Glycoproteins (Glycoprotein)IBA 10/2020 - 03/2006
2	OligonucleotidesIBA 07/2020 - 02/2017
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020 - 01/2017

Therapy/Procedure

63	Therapeutics 12/2021 - 09/2002
10	Blood Component Removal (Apheresis) 11/2020 - 01/2003
5	Drug Therapy (Chemotherapy) 01/2022 - 03/2002
5	Colectomy 03/2021 - 04/2018
5	Remission Induction 01/2018 - 05/2005
3	Restorative Proctocolectomy 05/2021 - 05/2018
2	Operative Surgical Procedures 05/2021 - 12/2016
2	Transitional Care 01/2021 - 01/2021
2	Blood Transfusion (Blood Transfusions) 01/2021 - 12/2016